We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+14.32%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$889M
AUM Growth
-$164M
Cap. Flow
-$239M
Cap. Flow %
-26.87%
Top 10 Hldgs %
50.84%
Holding
103
New
31
Increased
13
Reduced
14
Closed
37

Top Buys

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$27.8M
2
MDT icon
Medtronic
MDT
+$25.2M
3
COO icon
Cooper Companies
COO
+$10.7M
4
DXCM icon
DexCom
DXCM
+$9.85M
5
FMS icon
Fresenius Medical Care
FMS
+$8.86M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$43.3M
2
HUM icon
Humana
HUM
+$28M
3
UHS icon
Universal Health Services
UHS
+$24M
4
BDX icon
Becton Dickinson
BDX
+$17.5M
5
CI icon
Cigna
CI
+$16.5M

Sector Composition

Rank Sector Weight
1 Healthcare 95.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELV icon
76
Elevance Health
ELV
$84.7B
– –
-80,000
Closed -$43.3M
EW icon
77
Edwards Lifesciences
EW
$54B
– –
-150,000
Closed -$13.9M
GMED icon
78
Globus Medical
GMED
$11.4B
– –
-125,000
Closed -$8.56M
HOLX
79
DELISTED
Hologic
HOLX
– –
-50,000
Closed -$3.71M
HUM icon
80
Humana
HUM
$44.8B
– –
-75,000
Closed -$28M
ICLR icon
81
Icon
ICLR
$12.8B
– –
-45,000
Closed -$14.1M
IONS icon
82
CALL
Ionis Pharmaceuticals
IONS
$9.21B
– –
-500,000
Closed -$23.8M
IONS icon
83
Ionis Pharmaceuticals
IONS
$9.21B
– –
-250,000
Closed -$11.9M
ISRG icon
84
Intuitive Surgical
ISRG
$142B
– –
-10,000
Closed -$4.45M
KRYS icon
85
Krystal Biotech
KRYS
$9.68B
– –
-85,000
Closed -$15.6M
KURA icon
86
Kura Oncology
KURA
$882M
– –
-100,000
Closed -$2.06M
MCK icon
87
McKesson
MCK
$105B
– –
-20,000
Closed -$11.7M
MRUS
88
DELISTED
Merus
MRUS
– –
-100,000
Closed -$5.92M
NBIX icon
89
Neurocrine Biosciences
NBIX
$16.5B
– –
-70,000
Closed -$9.64M
OSCR icon
90
Oscar Health
OSCR
$8.63B
– –
-500,000
Closed -$7.91M
PODD icon
91
Insulet
PODD
$10B
– –
-25,000
Closed -$5.04M
RGEN icon
92
Repligen
RGEN
$9.3B
– –
-60,000
Closed -$7.56M
RLAY icon
93
Relay Therapeutics
RLAY
$4.38B
– –
-750,000
Closed -$4.89M
ROIV icon
94
Roivant Sciences
ROIV
$25.5B
– –
-400,000
Closed -$4.23M
SGRY icon
95
Surgery Partners
SGRY
$1.96B
– –
-200,000
Closed -$4.76M
SNY icon
96
Sanofi
SNY
$104B
– –
-200,000
Closed -$9.7M
SYRE icon
97
Spyre Therapeutics
SYRE
$9.06B
– –
-100,000
Closed -$2.35M
TARS icon
98
PUT
Tarsus Pharmaceuticals
TARS
$3.05B
– –
-400,000
Closed -$10.9M
TMO icon
99
Thermo Fisher Scientific
TMO
$224B
– –
-25,000
Closed -$13.8M
UHS icon
100
Universal Health Services
UHS
$9.94B
– –
-130,000
Closed -$24M
1 2 3
4
5

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, Integral Health Asset Management held 103 positions worth $889M, down 16% from $1.05B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Integral Health Asset Management withdrew a net $239M in Q3 2024, closing 37 positions and reducing 14 holdings. Its most notable exit was Elevance Health, an estimated $43.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier.

Against the trend, Integral Health Asset Management opened a new position in Inspire Medical Systems worth $33.8M.

  • Integral Health Asset Management's largest Q3 2024 buy was Inspire Medical Systems: 160,000 shares worth $33.8M.
  • Integral Health Asset Management added most to Keros Therapeutics in Q3 2024, an estimated $5.68M increase.
  • Integral Health Asset Management's biggest Q3 2024 reduction was Cytokinetics, cutting an estimated $13.9M.
  • Integral Health Asset Management fully exited Elevance Health in Q3 2024, selling an estimated $43.3M.
  • Integral Health Asset Management's ten largest holdings make up 51% of its $889M portfolio in Q3 2024.
  • Integral Health Asset Management opened 31 new positions and closed 37 in Q3 2024.
  • Integral Health Asset Management's portfolio value fell 16% quarter-over-quarter to $889M.

Based on Integral Health Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.